Stock Updates

Morning Trending Tickers: Thermo Fisher Scientific Inc., (TMO)

Friday February 24th 2017: Thermo Fisher Scientific Inc., TMO is in the exchange NYSE and its industry is Medical Laboratories & Research in the sector of Healthcare. Based in USA, Thermo Fisher Scientific Inc., TMO  has a market cap of 70.71 B. Since its IPO date on the 09/01/1987, Thermo Fisher Scientific Inc., TMO performance year to date is 27.59%. Today Thermo Fisher Scientific Inc., TMO has gained -0.30%, with a current price of 179.49.

Ownership of the company is 0.20% for insider ownership while institutional ownership is 89.60%. The management of the company have seen the company have a payout ratio of 10.90%. Return of assets are at 4.80%, with return on investment at 6.40%.

In terms of debt levels and profit levels, Thermo Fisher Scientific Inc., TMO is seeing a long-term debt/equity of 0.7. While Total debt/equity is 0.78. With a profit margin of 11.60%, this is combined with a gross margin of 45.90%, and operating margin of 13.60%. Thermo Fisher Scientific Inc. ability to meet debt levels, with a current ratio of 1.4, while the quick ratio is 0.9.

For the last year Thermo Fisher Scientific Inc., TMO has seen a EPS growth of 3.50%. A performance for the year of 16.30%. The 52-week high is -0.68%, and the 52-week low is 29.06%. The average volume for Thermo Fisher Scientific Inc., TMO is 32785.

With a target price of 186.81, can Thermo Fisher Scientific Inc., TMO reach this target? Looking at the value indicators of Thermo Fisher Scientific Inc., TMO. Thermo Fisher Scientific Inc. has a P/E of 32.8 and a forward P/E of 17.64. Perhaps the more useful indicator than P/E, is PEG which has a value of 3.02. Thermo Fisher Scientific Inc. also has a P/S and a P/B of 3.77 and 3.23 respectively. For P/cash, Thermo Fisher Scientific Inc. has a value of 97.55, while it is 29.35 for P/free cash flow.

At the current price of 179.49, Thermo Fisher Scientific Inc. has a dividend yield of 0.33%. We see a return on equity of 10.10%.

Looking more long-term Thermo Fisher Scientific Inc., is projected to get an EPS growth for the next five years of 10.85%. In the short-term an EPS growth of 10.68% in the next year is forecasted. This is after a EPS growth of 3.50% for this year and for the last five years a 13.90% growth has been seen.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment